Frontiers | Interferon-γ-induced tolerogenic dendritic cells ameliorate autoimmune neuroinflammation and suppress T-cell responses in multiple sclerosis

The brief

Researchers have discovered a potential treatment for multiple sclerosis, a chronic autoimmune disease affecting the central nervous system. Interferon-γ-induced tolerogenic dendritic cells have been found to reduce autoimmune neuroinflammation and suppress T-cell responses in multiple sclerosis patients. This breakthrough could lead to new therapeutic approaches for managing the disease. The study's findings may have significant implications for improving treatment outcomes and quality of life for individuals with multiple sclerosis. The research was published in the scientific journal Frontiers.

Auto-summarised from the full article